These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 25733347)

  • 1. Toward beta cell replacement for diabetes.
    Johannesson B; Sui L; Freytes DO; Creusot RJ; Egli D
    EMBO J; 2015 Apr; 34(7):841-55. PubMed ID: 25733347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to make insulin-producing pancreatic β cells for diabetes treatment.
    Lu J; Xia Q; Zhou Q
    Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell replacement for insulin-dependent diabetes mellitus.
    Efrat S
    Adv Drug Deliv Rev; 2008 Jan; 60(2):114-23. PubMed ID: 18022276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for diabetes: potential role of stem cells.
    Stanekzai J; Isenovic ER; Mousa SA
    Diabetes Res Clin Pract; 2012 Dec; 98(3):361-8. PubMed ID: 23020931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of β-cells for autologous transplantation in type 1 diabetes.
    Schuetz C; Markmann JF
    Pharmacol Res; 2015 Aug; 98():60-8. PubMed ID: 25801943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accessory cells for β-cell transplantation.
    Staels W; De Groef S; Heremans Y; Coppens V; Van Gassen N; Leuckx G; Van de Casteele M; Van Riet I; Luttun A; Heimberg H; De Leu N
    Diabetes Obes Metab; 2016 Feb; 18(2):115-24. PubMed ID: 26289770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From stem cells to functional beta cells in type 1 diabetes].
    Engberg N; Hansson M; Madsen OD
    Ugeskr Laeger; 2010 Sep; 172(38):2608-12. PubMed ID: 20920405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges.
    Quiskamp N; Bruin JE; Kieffer TJ
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The state of the art of islet transplantation and cell therapy in type 1 diabetes.
    Pellegrini S; Cantarelli E; Sordi V; Nano R; Piemonti L
    Acta Diabetol; 2016 Oct; 53(5):683-91. PubMed ID: 26923700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correction of autoimmune mechanisms underlying the development of type I diabetes mellitus by methods of cell therapy].
    Velikiĭ DA; Zakir'ianov AR; Klimenko ED; Kobozeva LP; Michunskaia AB; Pozdniakov OM
    Vestn Ross Akad Med Nauk; 2010; (9):34-42. PubMed ID: 21089446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Horizons in the Treatment of Type 1 Diabetes: More Intense Immunosuppression and Beta Cell Replacement.
    Couri CEB; Malmegrim KCR; Oliveira MC
    Front Immunol; 2018; 9():1086. PubMed ID: 29868031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell replacement strategies aimed at reconstitution of the β-cell compartment in type 1 diabetes.
    Orlando G; Gianello P; Salvatori M; Stratta RJ; Soker S; Ricordi C; Domínguez-Bendala J
    Diabetes; 2014 May; 63(5):1433-44. PubMed ID: 24757193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-cell replacement in immunosuppressed recipients: old and new clinical indications.
    Bertuzzi F; Ricordi C
    Acta Diabetol; 2007 Dec; 44(4):171-6. PubMed ID: 17924054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapy for type 1 diabetes: autologous hematopoietic stem cell transplantation.
    Li L; Gu W; Zhu D
    J Diabetes; 2012 Dec; 4(4):332-7. PubMed ID: 23190701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Cell replacement as a treatment for type 1 diabetes: an overview of possible cell sources and current axes of research.
    Vieira A; Courtney M; Druelle N; Avolio F; Napolitano T; Hadzic B; Navarro-Sanz S; Ben-Othman N; Collombat P
    Diabetes Obes Metab; 2016 Sep; 18 Suppl 1():137-43. PubMed ID: 27615143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death and dysfunction of transplanted β-cells: lessons learned from type 2 diabetes?
    Potter KJ; Westwell-Roper CY; Klimek-Abercrombie AM; Warnock GL; Verchere CB
    Diabetes; 2014 Jan; 63(1):12-9. PubMed ID: 24357689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-cell regeneration and differentiation: how close are we to the 'holy grail'?
    Tan G; Elefanty AG; Stanley EG
    J Mol Endocrinol; 2014 Dec; 53(3):R119-29. PubMed ID: 25385843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus: a potential target for stem cell therapy.
    Burns CJ; Persaud SJ; Jones PM
    Curr Stem Cell Res Ther; 2006 May; 1(2):255-66. PubMed ID: 18220871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta cell replacement for the treatment of diabetes.
    Oberholzer J; Toso C; Ris F; Bucher P; Triponez F; Demirag A; Lou J; Morel P
    Ann N Y Acad Sci; 2001 Nov; 944():373-87. PubMed ID: 11797687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.